Taipei Exchange - Delayed Quote TWD

DV Biomed Co., Ltd. (6539.TWO)

81.00
+1.80
+(2.27%)
At close: 2:56:20 PM GMT+8
Loading Chart for 6539.TWO
  • Previous Close 79.20
  • Open 79.20
  • Bid 79.00 x --
  • Ask 81.00 x --
  • Day's Range 78.80 - 82.70
  • 52 Week Range 57.80 - 153.57
  • Volume 42,395
  • Avg. Volume 11,843
  • Market Cap (intraday) 564.853M
  • Beta (5Y Monthly) 0.14
  • PE Ratio (TTM) 16.30
  • EPS (TTM) 4.97
  • Earnings Date --
  • Forward Dividend & Yield 2.80 (3.54%)
  • Ex-Dividend Date May 28, 2025
  • 1y Target Est --

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company also provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skin care; and beauty products and services. The company was founded in 2011 and is based in Taipei, Taiwan.

www.dvbiomed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6539.TWO

View More

Performance Overview: 6539.TWO

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6539.TWO
30.23%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.66%

1-Year Return

6539.TWO
38.35%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.76%

3-Year Return

6539.TWO
82.34%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
37.25%

5-Year Return

6539.TWO
67.36%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
100.93%

Compare To: 6539.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6539.TWO

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    552.30M

  • Enterprise Value

    303.44M

  • Trailing P/E

    15.94

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.49

  • Price/Book (mrq)

    1.03

  • Enterprise Value/Revenue

    0.53

  • Enterprise Value/EBITDA

    2.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.30%

  • Return on Assets (ttm)

    6.21%

  • Return on Equity (ttm)

    14.02%

  • Revenue (ttm)

    1.46B

  • Net Income Avi to Common (ttm)

    52.67M

  • Diluted EPS (ttm)

    4.97

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    274.59M

  • Total Debt/Equity (mrq)

    6.47%

  • Levered Free Cash Flow (ttm)

    -101.52M

Research Analysis: 6539.TWO

View More

Company Insights: 6539.TWO

Research Reports: 6539.TWO

View More

People Also Watch